TR201915555A2 - Pharmaceutical gel formulation containing tolperisone hydrochloride - Google Patents

Pharmaceutical gel formulation containing tolperisone hydrochloride

Info

Publication number
TR201915555A2
TR201915555A2 TR2019/15555A TR201915555A TR201915555A2 TR 201915555 A2 TR201915555 A2 TR 201915555A2 TR 2019/15555 A TR2019/15555 A TR 2019/15555A TR 201915555 A TR201915555 A TR 201915555A TR 201915555 A2 TR201915555 A2 TR 201915555A2
Authority
TR
Turkey
Prior art keywords
formulation containing
gel formulation
tolperisone hydrochloride
pharmaceutical gel
containing tolperisone
Prior art date
Application number
TR2019/15555A
Other languages
Turkish (tr)
Inventor
Türkkan Seyhan
Pehli̇van Akalin Nur
Türkyilmaz Ali̇
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2019/15555A priority Critical patent/TR201915555A2/en
Publication of TR201915555A2 publication Critical patent/TR201915555A2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş, en az bir penetrasyon arttırıcı ve bir veya daha fazla jelleştirici alan içeren topikal farmasötik tolperizon hidroklorür kompozisyonları ile ilgilidir.The present invention relates to topical pharmaceutical tolperisone hydrochloride compositions comprising at least one penetration enhancer and one or more gelling areas.

TR2019/15555A 2019-10-10 2019-10-10 Pharmaceutical gel formulation containing tolperisone hydrochloride TR201915555A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2019/15555A TR201915555A2 (en) 2019-10-10 2019-10-10 Pharmaceutical gel formulation containing tolperisone hydrochloride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2019/15555A TR201915555A2 (en) 2019-10-10 2019-10-10 Pharmaceutical gel formulation containing tolperisone hydrochloride

Publications (1)

Publication Number Publication Date
TR201915555A2 true TR201915555A2 (en) 2021-04-21

Family

ID=76503355

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/15555A TR201915555A2 (en) 2019-10-10 2019-10-10 Pharmaceutical gel formulation containing tolperisone hydrochloride

Country Status (1)

Country Link
TR (1) TR201915555A2 (en)

Similar Documents

Publication Publication Date Title
CY1124592T1 (en) 3-PHENYLISOXAZOLINE-5-CARBOXAMIDES HERBICIDIC ACTIVE FORMULATED FROM TETRAHYDRO- AND DIHYDROFURANCARBOXYLIC ACIDS AND ESTERS
BR112017012351A2 (en) bcl x1 inhibitor compounds that have low cell permeability and drug-antibody conjugates that include the same
CY1110602T1 (en) PHARMACEUTICAL COMPOSITIONS IN THE FORM OF GEL OR SOLUTION BASED ON DIABROSTEOSTERONE, METHODS OF PREPARATION AND USES
BR112018012756A2 (en) heterocyclic compounds as immunomodulators
BRPI0606112B8 (en) 3-hetero-aryl-3-hydroxy-2-amino-propyl amines and compounds related to analgesic activity, their use and pharmaceutical composition comprising them
CY1111926T1 (en) COOPERATIVE COMPOSITIONS WITH FK-228
EA200601596A1 (en) IMPROVED 6-MERCAPTOPURIN COMPOSITION
BR112022017508A2 (en) EGFR, KRAS, BRAF AND OTHER TARGET INHIBITORS AND THEIR USE
EA202090732A1 (en) TRANSDERMAL ADMINISTRATION FORMULATIONS
BR112022017192A2 (en) TRANSGLUTAMINASE VARIANTS
MX2019014449A (en) Low-alcohol and sterilizable antimicrobial compositions and use thereof.
EP3539978A4 (en) Nkx3.2 fragment and pharmaceutical composition comprising same as active ingredient
CL2019001550A1 (en) Topical phenytoin for use in the treatment of peripheral neuropathic pain.
TR201915555A2 (en) Pharmaceutical gel formulation containing tolperisone hydrochloride
BR112017024126B8 (en) PHARMACEUTICAL COMPOSITIONS, MICRONIZED COMPOUND A AND/OR AT LEAST ONE MICRONIZED PHARMACEUTICALLY ACCEPTABLE SALT OF COMPOUND A AND USE THEREOF
BR112019008606A2 (en) inhibitors of mtor-deptor interactions and methods of using them
BRPI0515040A (en) testosterone gels comprising propylene glycol as a penetration enhancer
BR112022008655A2 (en) PH-RESPONSIVE BLOCK COPOLYMER COMPOSITIONS, MICELLES, AND METHODS OF USE
FR3096892B1 (en) Anti-inflammatory composition comprising constituents of plant origin
JOP20180128A1 (en) Orally-dispersible solid pharmaceutical formulation
PE20191483A1 (en) MICROENCAPSULATED NITRIFICATION INHIBITING COMPOSITIONS
CY1110499T1 (en) 4-hydroxy tamoxifen gel preparations
TR201914420A2 (en) PHARMACEUTICAL FORMULATIONS CONTAINING SAPROPTERIN DIHYDROCHLORIDE AND AT LEAST ONE ANTIOXIDANT
BR112022023448A2 (en) NOTCH INHIBITORS AND THEIR USES
TR201722970A2 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING FLURBIPROPHEN-LIDOCAIN AND CETYLPYRIDINUM